Quantcast

Latest Desogestrel Stories

2014-03-27 23:01:09

Kristine K. Kraft, Plaintiffs' Liaison Counsel and Co-Lead Counsel in the NuvaRing® MDL, provides an update on the NuvaRing® Multidistrict Litigation (MDL 2385), particularly that the deadline for the submission of eligible claimants’ opt-in forms has been extended until April 9, 2014. St. Louis, Missouri (PRWEB) March 27, 2014 A $100 Million settlement was approved by United States District Court Judge Rodney W. Sippel in the NuvaRing® Multidistrict Litigation In re:...

2014-03-13 23:26:38

Kristine K. Kraft, Plaintiffs' Liaison Counsel and Co-Lead Counsel in the NuvaRing® MDL, provides an update on the NuvaRing® Multidistrict Litigation (MDL 2385), particularly that the deadline for the submission of eligible claimants’ opt-in forms has now been extended until March 25, 2014. St. Louis, MO (PRWEB) March 13, 2014 On February 7, 2014, United States District Court Judge Rodney W. Sippel approved a $100 Million settlement in the NuvaRing® Multidistrict...

2014-02-09 23:01:36

Roger Denton, Plaintiffs' Lead Counsel and one of the lead negotiators for the plaintiffs in the NuvaRing® MDL, reports that a $100 Million settlement has been reached with Merck to settle all NuvaRing® cases nationwide. St. Louis, MO (PRWEB) February 09, 2014 On February 7, 2014, United States District Court Judge Rodney W. Sippel approved a $100 Million settlement in the NuvaRing® Multidistrict Litigation In re: NuvaRing® Products Liability Litigation (MDL No....

2012-06-15 06:23:31

(Ivanhoe Newswire) -- A 15-year Danish historical cohort study was done to see how hormonal contraception can cause thrombotic stroke (blood clotting inside a brain artery) and myocardial infarction (heart attack). In this study, 1,626,158 non-pregnant women from the ages of 15 to 49 years old were observed. During the study 3,311 thrombotic strokes and 1,725 myocardial infarctions occurred. The current use of oral contraceptive that included ethinyl estradiol (bio-active estrogen) at a...

2011-12-13 08:00:00

Ennis & Ennis, P.A. Explains FDA Advisory Committee Meeting Outcome Regarding Yaz and Yasmin (PRWEB) December 13, 2011 The US Food and Drug Administration (FDA) advisory committee voted 21-5 on Thursday that labeling on Bayer's popular Yaz and similar birth control pills is inadequate and should be revised to better reflect the higher risk of blood clots associated with these drugs, compared with older oral contraceptives. Ennis & Ennis, P.A. explains the panelists want the label...

FDA Considers Blood Clot Warning On Birth Control Pill Yaz
2011-12-07 14:01:11

The Food and Drug Administration said on Tuesday that they are leaning towards adding new information about the risk of blood clots to labels of birth control pills. The FDA said there is conflicting evidence about the risk, but the information should still appear in labeling used by doctors and patients. "We believe that, because of the consistency in recent reports for an increased risk, product labeling should reflect that very real possibility," the FDA said. The agency will ask...

2011-11-09 16:40:00

Ennis & Ennis, P.A. explains the findings of another recent study revealing the significant risk of developing dangerous blood blots associated with birth control pills such as Yaz and Yasmin. (PRWEB) November 09, 2011 The Canadian Medical Association Journal released a study of 330,000 Israeli women indicating that blood clots were more likely for those who were taking Yaz and Yasmin, which are birth control pills that contain the synthetic hormone drospirenone, reported attorney David...

2011-11-08 06:47:39

(Ivanhoe Newswire) — Drospirenone-containing oral birth control pills are linked to a significantly higher risk of blood clots, both deep vein thrombosis and pulmonary embolism, according to this study. All oral contraceptives are associated with a higher risk of blood clots, but there is conflicting information about the risk of adverse events with drospirenone. Many previous studies have evaluated risks of second- and third-generation contraceptives, which both contain derivatives...

2011-10-28 07:00:00

Women Who Take Certain Oral Contraceptive Pills such as Yaz or Yasmin Are More Likely to Develop Venous Thromboembolism, Explains Ennis & Ennis, P.A. (PRWEB) October 28, 2011 A study published on October 25, 2011 by The British Medical Journal confirms previous findings that certain oral contraceptives containing newer types of progestogen hormones (drospirenone, desogestrel or gestodene), which are found in Yaz or Yasmin, at least double the risk of developing venous thromboembolism...

2011-10-26 12:49:51

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9 A study published on http://www.bmj.com today confirms previous findings that certain oral contraceptive pills are more likely to cause serious blood clots (venous thromboembolism - VTE ) than others. The authors, led by Dr Øjvind Lidegaard from the University of Copenhagen, say that women on pills containing one of the newer...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.